“…There have been two convincing reports demonstrating that warfarin is not detected in breast milk and does not induce an anticoagulant effect in the breast-fed infant when nursing mothers consume the drug. 98,99 Acenocoumarol, which is commonly used in Europe, has similar properties (Tables S4, S5). 100,101 Therefore, the use of warfarin and acenocoumarol in women who require postpartum anticoagulant therapy is safe.…”
Section: Use Of Vitamin K Antagonists In Breast-feeding Womenmentioning
Summary of RecommendationsNote on Shaded Text: Throughout this guideline, shading is used within the summary of recommendations sections to indicate recommendations that are newly added or have been changed since the publication of Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Recommendations that remain unchanged are not shaded. Abbreviations: APLA 5 antiphospholipid antibody; aPPT 5 activated partial thromboplastin time; HIT 5 heparin-induced thrombocytopenia; INR 5 international normalized ratio; LMWH 5 low-molecular-weight heparin; NNT 5 number needed to treat; PE 5 pulmonary embolism; RR 5 risk ratio; UFH 5 unfractionated heparin
“…There have been two convincing reports demonstrating that warfarin is not detected in breast milk and does not induce an anticoagulant effect in the breast-fed infant when nursing mothers consume the drug. 98,99 Acenocoumarol, which is commonly used in Europe, has similar properties (Tables S4, S5). 100,101 Therefore, the use of warfarin and acenocoumarol in women who require postpartum anticoagulant therapy is safe.…”
Section: Use Of Vitamin K Antagonists In Breast-feeding Womenmentioning
Summary of RecommendationsNote on Shaded Text: Throughout this guideline, shading is used within the summary of recommendations sections to indicate recommendations that are newly added or have been changed since the publication of Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Recommendations that remain unchanged are not shaded. Abbreviations: APLA 5 antiphospholipid antibody; aPPT 5 activated partial thromboplastin time; HIT 5 heparin-induced thrombocytopenia; INR 5 international normalized ratio; LMWH 5 low-molecular-weight heparin; NNT 5 number needed to treat; PE 5 pulmonary embolism; RR 5 risk ratio; UFH 5 unfractionated heparin
“…There is convincing evidence that, when administered to a nursing mother, warfarin does not induce an anticoagulant effect in the breast-fed infant. 180,181 …”
Section: Anticoagulation During Pregnancymentioning
“…15 There were 2 convincing reports that warfarin does not induce an anticoagulant effect in the breast-fed infant when the drug is administered to a nursing mother, 16,17 and so it can also be given to women requiring anticoagulant therapy postpartum who wish to breast feed.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.